Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2005
10/06/2005US20050221434 Receptor of the EDb-fibronectin domains
10/06/2005US20050221433 IL-18 specific polypeptides and therapeutic uses thereof
10/06/2005US20050221432 Altering the cellular secretion rate of a protein comprising the steps of modulating the activity of at least one UPR pathway component in a cell and culturing the cell; useful for producing high levels of proteins for therapeutic, diagnostic or research purposes
10/06/2005US20050221430 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
10/06/2005US20050221429 Host cells containing multiple integrating vectors comprising an amplifiable marker
10/06/2005US20050221424 Bispecific molecules for use in therapy and diagnosis of immune related and other diseases
10/06/2005US20050221420 Nogo receptor homologues and their use
10/06/2005US20050221400 Monoclonal antibody comprising an antigen binding site that binds specifically to PSCA protein wherein monoclonal antibody comprises the amino acid sequence of the variable heavy chain region and the variable light chain region of antibody secreted by hybridoma assigned A.T.C.C. Accession No.: PTA-6697
10/06/2005US20050221394 Ion channel
10/06/2005US20050221387 Fluorescence analysis method using fluorescent-activating antibodies
10/06/2005US20050221383 Osteoarthritis biomarkers and uses thereof
10/06/2005US20050221380 Method for determination of the responsiveness of an individual to mistletoe lectin
10/06/2005US20050221372 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
10/06/2005US20050221371 Diagnosis of diseases related to an alteration in the regulation or in the coding regions of the RBP-7 gene and for prognosis/diagnosis of an eventual treatment with agents acting on pathologies involving abnormal cell proliferation and/or abnormal cell differentiation.
10/06/2005US20050221346 May be used to detect the presence of a cancer or to evaluate the prognosis of a known disease
10/06/2005US20050221344 Interferon-Like molecules and uses thereof
10/06/2005US20050221330 Glial cell line-derived neurotrophic factor (GDNF); nervous system disorders, autonomic nervous system, shingles, asthma, irritable bowel, inflammatory bowel, constipation, headache, arthritis, spinal cord injury, chronic back pain, hypertension, mucositis, diabetes, fibromyalgia, and wound healing
10/06/2005US20050221325 Detection of secreted polypeptides
10/06/2005US20050221317 Use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
10/06/2005US20050221311 Isolated human transporter proteins nucleic acid molecules encoding human transporter proteins and used thereof
10/06/2005US20050221303 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/06/2005US20050221298 Anti-idiotypic antibody and its use in diagnosis and therapy in HIV-related disease
10/06/2005US20050221296 Comprises peptide for genotyping and detecting hepatitis viral infection; immunoassay; antigenic peptides of HCV immobilized on solid substrate
10/06/2005US20050221284 Heteropolymer complexes and methods for their use
10/06/2005US20050220894 Colostrum-based composition
10/06/2005US20050220805 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines
10/06/2005US20050220804 Increasing an immune response in an animal, comprising administering a compound (such as a carbohydrate, an antibiotic, a sugar, a protein, or an antibody) that binds a C-type lectin (but not the DEC-205 receptor) on the surface of a dendritic cell
10/06/2005US20050220797 Prophylactic and therapeutic monoclonal antibodies
10/06/2005US20050220796 Compositions and methods for modulating DNA repair
10/06/2005US20050220795 Complementarity determining regions which bind to catalytic domain of aspartyl (asparaginyl) beta -hydroxylase; diagnosis and treatment of cancer; readily penetrates tumors, no side effects, less toxic
10/06/2005US20050220794 Growth/differentiation factor of the TGF-beta family
10/06/2005US20050220793 Anti-tissue factor antibodies and compositions
10/06/2005US20050220791 Novel of cytokine inhibitors
10/06/2005US20050220789 T cell immune response cDNA 7 (TIRC7) protein for use in treatment of organ transplantation rejection, tumor, autoimmune and/or allergic disorders
10/06/2005US20050220788 Use of molecules which interact with the haptoglobin receptor ligand binding
10/06/2005US20050220787 Naturally occuring IgM antibodies that bind to lymphocytes
10/06/2005US20050220786 Lyophilised preparation comprising antibodies against the efg receptor
10/06/2005US20050220783 Antibody production in farm animals
10/06/2005DE102004022298A1 Test kit for enzyme immunoassay identification of human cathepsin K, in blood and other body fluids, has separate packages containing antibodies bonded to micro-titration plates, standard human recombinant cathepsin K and buffers
10/06/2005CA2564989A1 Reducing the risk of human and anti-human antibodies through v gene manipulation
10/06/2005CA2561495A1 Truncated dance, dance complex and method of using these
10/06/2005CA2561264A1 Immunoglobulin variants outside the fc region
10/06/2005CA2561192A1 Cancerous disease modifying antibodies
10/06/2005CA2560919A1 Uses of anti-ctla-4 antibodies
10/06/2005CA2560903A1 Use of emmprin antagonists for the treatment of diseases associated with excessive angiogenesis
10/06/2005CA2560864A1 Cytotoxicity mediation of cells evidencing surface expression of cd63
10/06/2005CA2560862A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp
10/06/2005CA2560859A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
10/06/2005CA2560742A1 Receptor coupling agents and therapeutic uses thereof
10/06/2005CA2560508A1 Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation
10/06/2005CA2559480A1 Methods and compositions for inhibition of metastasis
10/06/2005CA2557724A1 Methods and compositions for treating il-13 related pathologies
10/05/2005EP1582218A1 Compositions for the treatment of mycobacterial infections
10/05/2005EP1581759A2 Methods for treating taxol-induced sensory neuropathy
10/05/2005EP1581644A1 Purification of polypeptides
10/05/2005EP1581620A2 Antibodies that recognize hyperproliferative cells and methods of making and using same
10/05/2005EP1581618A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/05/2005EP1581616A2 Novel proteins and nucleic acids encoding same
10/05/2005EP1581560A1 Anti-idiotypic antibodies against factor viii inhibitor and uses thereof
10/05/2005EP1581559A2 Fc fusion
10/05/2005EP1581552A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
10/05/2005EP1581244A1 Novel therapeutic targets in cancer
10/05/2005EP1581242A2 Compositions and methods for modifying toxic effects of proteinaceous compounds
10/05/2005EP1581171A2 Antibodies against gpr64 and uses thereof
10/05/2005EP1581096A2 Antigen pipa and antibodies that bind thereto
10/05/2005EP1263430B1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
10/05/2005EP0914157B1 Anti-tnf antibodies / tnf receptor and methotrexate in the treatment of autoimmune disease
10/05/2005CN1678912A Plasma urotensin in human heart failure
10/05/2005CN1678744A Human antihuman interleukin-6 antibody and fragment of the antibody
10/05/2005CN1678740A Antibody against N-terminal peptide or C-terminal peptide of GPC3 solubilized in blood
10/05/2005CN1678735A Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor
10/05/2005CN1678734A Differentiation modulating agents and uses therefor
10/05/2005CN1678635A Specific antibodies proBNP(1-108) for diagnosing heart failure
10/05/2005CN1678634A Immunoglobulin single variable antigen combination area and its opposite constituent
10/05/2005CN1678633A Anti-IGF-I receptor antibody
10/05/2005CN1678628A Stress proteins and peptides and methods of use thereof
10/05/2005CN1678625A Humanized anti-lymphotoyin beta receptor antibodies
10/05/2005CN1678349A Compositions against chicken coccidiosis
10/05/2005CN1678348A Compositions and methods for therapeutic treatment
10/05/2005CN1678347A Antibodies and uses thereof
10/05/2005CN1677107A Immune antibody for testing residual of polyether-like antibiotic and use thereof
10/05/2005CN1676610A Novel penicillium marneffei PPIase II, its coding sequence and use
10/05/2005CN1676609A Novel penicillium marnffei PPIase II, its coding sequence and use
10/05/2005CN1676608A Novel penicillium marneffei ERG1 gene, its coding protein and use
10/05/2005CN1221569C Cell surface molecule mediating cell adhesion and signal transmission
10/05/2005CN1221566C gClq receptor jointed HIV-lgp120 relative peptide and coded oligonucleotide thereof
10/04/2005US6951926 Antibody to bladder cancer nuclear matrix protein and its use
10/04/2005US6951925 comprises antibody which binds an epitope of the p60 protein from pathogenic Listeria monocytogenes; immunology
10/04/2005US6951923 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
10/04/2005US6951922 Antibodies immunologically reactive with broad-spectrum delta endotoxins
10/04/2005US6951921 Genetic engineered protein drugs, such as thrombolytic agents, interferons, interleukins, erythropoietins; extracellular
10/04/2005US6951920 PRO1340 polypeptides
10/04/2005US6951845 Method for treating allergic lung disease
10/04/2005US6951742 Polyclonal and monoclonal antibodies to antigens in poultry or birds, formed using polynucleotide vaccines; proteomics
10/04/2005US6951738 Human tumor necrosis factor receptors TR13 and TR14
10/04/2005US6951732 Virulence genes, proteins, and their use
10/04/2005US6951727 Measuring human leukocyte antigen expression on the surface of erythrocytes; obtain cells, incubate with chloroqiune, monitor binding of preferential antibody to cells
10/04/2005US6951647 T cell binding ligand peptides and method of inducing a cellular immune response
10/04/2005US6951646 recognizing conformation dependent epitopes of HCV glycoprotein E2 that are capable of neutralizing the binding of E2 protein onto susceptible cells
10/04/2005US6951645 Using antibodies; blocking receptors; anticoagulants
1 ... 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 ... 1494